Ikris Pharma Network- A Generic Medication Supplier

The demand for generic medicines is increasing at the global level and pharmaceutical companies are realising the huge potential this opportunity affords. Efficient as well as inexpensive drugs are always required, making this a growing market for the drug makers. The market for generic drugs at the global level is projected to rise at a compound annual growth rate (CAGR) of 8.7%; meaning that, in the forecast period 2016 to 2021, the global market for generic medicines will boost from $352 to $533 billion.

Ikris Pharma Network founded in 2014 and is based in Noida, India. We are one of the most reliable pharmaceutical companies for generic medication supplies across the globe, making it a key player in the industry.

We are an internationally acclaimed pharmaceutical wholesaler and service company providing a gamut of services specifically in the field of medications. We are a reputed name at the global level when it comes to high quality generic medicines. Our world-class approach and facilities along with a talented team works day and night to ensure the best possible services. 

As a result, we are certified by the highest authorities like ISO 9001:2008, GMP, WHO, GDP, etc. We have a diversified products line across all the crucial aspects of healthcare. This includes Heart Disease, Cancer, and HIV, etc. We have a reliable network as generic drugs exporters across more than 100 countries worldwide. We have Served 50000+ patients, Supplied more than 5000 products line across 150+ countries which include Africa, United States, UK, Gulf countries, Vietnam, Sri Lanka, South East Asia, Philippines, Cambodia, Poland and many more. 

Survey: As stated by the Indian Economic Survey 2021, the domestic market is anticipated to extend 3x in the forthcoming decade. India’s domestic pharmaceutical market is estimated at USD 42 billion in the year of 2021 and likely to reach USD 65 billion by the year of 2024 and further extend to reach USD 120 to 130 billion by the year of 2030.

India’s biotechnology industry comprises bio-industry, biopharmaceuticals, bio-services, bio-agriculture, and bioinformatics. The Indian biotechnology industry was valued at USD 64 billion in the year of 2019 and is anticipated to reach USD 150 billion by the year of 2025.

India’s drugs and pharmaceuticals exports stood at USD 24.44 billion in the Financial Year 2021.

Praveen Sikri, CEO of Ikris Pharma Network, says: “India is the largest producer of Generic Medicine in the world. There are more than 10500 manufacturing companies in India. There are more than 665 USA FDA approved manufacturing plants in India which is highest in number outside the USA. This reflects on the qualitative aspect of Indian Generic Medicines. Indian Pharmaceutical companies have the capacity and capability to produce Quality generic medicine at an economical price. Indian Government has provided a favourable environment for FDI in the Pharmaceutical Sector.” 

Kindly connect with us through our TOLL-FREE 18008891064 or Email us at info@ikrispharmanetwork.com in order to know more about our generic drug exports from India. We are absolutely keen to take all your queries.